44th week of 2016 patent applcation highlights part 24 |
Patent application number | Title | Published |
20160318915 | 3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH | 2016-11-03 |
20160318916 | NITROGEN-CONTAINING SIX-MEMBERED CYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | 2016-11-03 |
20160318917 | NRF2 REGULATORS | 2016-11-03 |
20160318918 | SMALL MOLECULE MODIFIERS OF THE HEC1-NEK2 INTERACTION IN G2/M | 2016-11-03 |
20160318919 | OXIME-SUBSTITUTED AMIDE COMPOUND AND PEST CONTROL AGENT | 2016-11-03 |
20160318920 | TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF | 2016-11-03 |
20160318921 | NOVEL GLUTAMINASE INHIBITORS | 2016-11-03 |
20160318922 | APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS | 2016-11-03 |
20160318923 | DIAZEPANE OREXIN RECEPTOR ANTAGONISTS | 2016-11-03 |
20160318924 | PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO | 2016-11-03 |
20160318925 | IMIDAZO [1,2-a]PYRIDINE COMPOUNDS, SYNTHESIS THEREOF, AND METHODS OF USING SAME | 2016-11-03 |
20160318926 | MALEIMIDE DERIVATIVES AS MODULATORS OF WNT PATHWAY | 2016-11-03 |
20160318927 | P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS | 2016-11-03 |
20160318928 | TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS | 2016-11-03 |
20160318929 | PYRAZOLO[1,5-A]PYRIDINE DERIVATIVES AND METHODS OF THEIR USE | 2016-11-03 |
20160318930 | METHOD FOR TREATING PAIN SYNDROME AND OTHER DISORDERS | 2016-11-03 |
20160318931 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2016-11-03 |
20160318933 | FUSED PYRAZOLE DERIVATIVE | 2016-11-03 |
20160318934 | 2-METHYLSULPHANYL-6-NITRO-7-OXO-1, 2, 4-TRIAZOLO [5, 1-C] [1, 2, 4] TRIAZINIDE L-ARGININE DIHYDRATE ACTIVE TOWARD WEST NILE VIRUS | 2016-11-03 |
20160318935 | BIARYL BRUTON'S TYROSINE KINASE INHIBITORS | 2016-11-03 |
20160318936 | PYRIMIDOPYRIMIDINONES USEFUL AS WEE-1 KINASE INHIBITORS | 2016-11-03 |
20160318937 | PYRAZOLO[1,5-A]PYRIMIDINES AS ANTIVIRAL COMPOUNDS | 2016-11-03 |
20160318938 | CRYSTALS (2) OF PYRAZINO[2,1-c][1,2,4]TRIAZINE COMPOUND | 2016-11-03 |
20160318939 | Imidazopyrazinones as PDE1 Inhibitors | 2016-11-03 |
20160318940 | SOLID FORMS OF 1-ETHYL-7-(2-METHYL-6-(1H-1,2,4-TRIAZOL-3-YL)PYRIDIN-3-YL)-3,4-DIHYDROPYR- AZINO[2,3-b]PYRAZIN-2(1H)-ONE, COMPOSITIONS THEREOF AND METHODS OF THEIR USE | 2016-11-03 |
20160318941 | SUBSTITUTED [1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS | 2016-11-03 |
20160318942 | TETRAHYDRO-PYRIMIDOAZEPINES AS MODULATORS OF TRPV1 | 2016-11-03 |
20160318943 | IMIDAZOLE DERIVATIVE USED AS ANTIVIRAL AGENT AND USE THEROF IN PREPARATION OF MEDICAMENT | 2016-11-03 |
20160318944 | PIPERIDINYLOXY LACTONE OREXIN RECEPTOR ANTAGONISTS | 2016-11-03 |
20160318945 | TRITOQUALINE HYDROCHLORIDE IN CRYSTALLINE FORM AND A PROCESS FOR OBTAINING SAME | 2016-11-03 |
20160318946 | ALCOHOL-, DIOL-, AND CARBOHYDRATE-SUBSTITUTED INDENOISOQUINOLINES AS TOPOISOMERASE I INHIBITORS | 2016-11-03 |
20160318947 | PHARMACOLOGICALLY ACTIVE COMPOUNDS | 2016-11-03 |
20160318948 | Compounds Inhibiting Eukaryotic Elongation Factor 2 Kinase Activity | 2016-11-03 |
20160318949 | METHODS AND COMPOUNDS FOR SYNTHESIZING FUSED THIOPHENES | 2016-11-03 |
20160318950 | FUSED BICYCLIC ISOXAZOLINES AS INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN | 2016-11-03 |
20160318951 | Tetrahydro[1,8]naphthyridine Sulfonamide And Related Compounds for Use as Agonists of RORy and the Treatment of Disease | 2016-11-03 |
20160318952 | 5-ARYL-1-IMINO-1-OXO-[1,2,4]THIADIAZINES | 2016-11-03 |
20160318953 | Selective BACE1 Inhibitors | 2016-11-03 |
20160318954 | 1H-PYRAZOLO[3,4-B]PYRIDINES AND THERAPEUTIC USES THEREOF | 2016-11-03 |
20160318955 | Boron-Containing Small Molecules as Anti-Inflammatory Agents | 2016-11-03 |
20160318956 | HYDROGENATION OF ESTERS WITH FE/TRIDENTATE LIGANDS COMPLEXES | 2016-11-03 |
20160318957 | CRYSTAL (1) OF PYRAZINO[2,1-c][1,2,4]TRIAZINE COMPOUND | 2016-11-03 |
20160318958 | UREA DERIVATIVES USEFUL AS KINASE INHIBITORS | 2016-11-03 |
20160318959 | NOVEL MONOPHOSPHITE COMPOUNDS HAVING A METHYL GROUP | 2016-11-03 |
20160318960 | NOVEL MONOPHOSPHITE COMPOUNDS HAVING AN ETHER GROUP | 2016-11-03 |
20160318961 | COMPLEXES AND CATALYTIC PROCESSES | 2016-11-03 |
20160318962 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF CANCERS | 2016-11-03 |
20160318963 | BASE METAL CATALYZED BORYLATION OF ARENES AND AROMATIC HETEROCYCLES | 2016-11-03 |
20160318964 | NOVEL FERROCENYL COMPOUNDS | 2016-11-03 |
20160318965 | Process for the Preparation of Empagliflozin | 2016-11-03 |
20160318966 | Process for the Preparation of Sofosbuvir | 2016-11-03 |
20160318967 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | 2016-11-03 |
20160318968 | URIDINE DIPHOSPHATE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS | 2016-11-03 |
20160318969 | SOLID FORMS OF A THIOPHOSPHORAMIDATE NUCLEOTIDE PRODRUG | 2016-11-03 |
20160318970 | NOVEL 7-DEAZAPURINE NUCLEOSIDES FOR THERAPEUTIC USES | 2016-11-03 |
20160318971 | NUCLEIC ACID COATED COLLOIDS | 2016-11-03 |
20160318972 | PREPARATION METHOD AND ANALYTIC METHOD FOR THE EXTRACT OF ANTRODIA CINNAMOMEA | 2016-11-03 |
20160318973 | COMPOSITIONS AND METHODS FOR INCREASING TELOMERASE ACTIVITY | 2016-11-03 |
20160318974 | METHOD OF LOADING A CRYSTALLIZATION DEVICE | 2016-11-03 |
20160318975 | METHOD FOR PROMOTING EXPRESSION OF CALRETICULIN, AND SYNTHETIC PEPTIDE FOR USE IN METHOD FOR PROMOTING EXPRESSION OF CALRETICULIN | 2016-11-03 |
20160318976 | BETA-HAIRPIN PEPTIDOMIMETICS AS SELECTIVE ELASTASE INHIBITORS | 2016-11-03 |
20160318977 | Melanocortin Receptor-Specific Peptides | 2016-11-03 |
20160318978 | Methods of Transcription Activator Like Effector Assembly | 2016-11-03 |
20160318979 | INTERACTION OF MORAXELLA CATARRHALIS WITH EPITHELIAL CELLS, EXTRACELLULAR MATRIX PROTEINS AND THE COMPLEMENT SYSTEM | 2016-11-03 |
20160318980 | Chemically Modified Graphene | 2016-11-03 |
20160318981 | POLYPEPTIDES TARGETING GLYCOSYLATED MUC2 PROTEINS, METHODS OF SYNTHESIS, THEIR NUCLEIC ACIDS AND USES THEREOF | 2016-11-03 |
20160318982 | METHOD FOR PREPARING SINGLE-VALENT, MODIFIED AVIDIN-LIKE MOLECULES AND MODIFIED FUNCTIONAL CONJUGATES | 2016-11-03 |
20160318983 | METHODS FOR TREATING FATTY LIVER DISEASE | 2016-11-03 |
20160318984 | PEPTIDE FOR PROMOTING OSTEOGENIC DIFFERENTIATION OR VASCULARIZATION AND USE THEREOF | 2016-11-03 |
20160318985 | Chimeric Virus-Like Particles Incorporating Fusion GPI Anchored GM-CSF and IL-4 Conjugates | 2016-11-03 |
20160318986 | IL-15 AND IL-15R\alpha SUSHI DOMAIN BASED IMMUNOCYTOKINES | 2016-11-03 |
20160318987 | PROTEASE RESISTANT PEPTIDES | 2016-11-03 |
20160318988 | T CELL RECEPTOR BINDING TO ALWGPDPAAA, DERIVED FROM HUMAN PRE-PRO INSULIN (PPI) PROTEIN | 2016-11-03 |
20160318989 | ISOFORM OF THE TGF-BETA RECEPTOR II | 2016-11-03 |
20160318990 | RECOMBINANT FIBRINOGEN HIGH-PRODUCTION LINE AND METHOD FOR PRODUCING SAME | 2016-11-03 |
20160318991 | Compounds Suitable for Treatment of Haemophilia | 2016-11-03 |
20160318992 | METHODS FOR DEPYROGENATION OF PROTEINS | 2016-11-03 |
20160318993 | OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION | 2016-11-03 |
20160318994 | METHODS OF USE OF SECRETORY IgA | 2016-11-03 |
20160318995 | Randomized Humanized Antibody Libraries Engineered with Sequence and Insert Diversity | 2016-11-03 |
20160318996 | TYPE III SECRETION SYSTEM TARGETING MOLECULES | 2016-11-03 |
20160318997 | Opsonic and Protective Monoclonal Antibodies Against Gram-Positive Pathogens | 2016-11-03 |
20160318998 | AFLATOXIN NANOBODY IMMUNOABSORBENT AND IMMUNOAFFINITY COLUMN AND PREPARATION METHOD AND USE THEREOF | 2016-11-03 |
20160318999 | VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders | 2016-11-03 |
20160319000 | DRG11-RESPONSIVE (DRAGON) GENE AND USES THEREOF | 2016-11-03 |
20160319001 | Motif-Specific and Context-Independent Antibodies That Specifically Bind to a Cleaved Caspase Motif | 2016-11-03 |
20160319002 | COMPOSITIONS AND METHODS OF TREATING OCULAR DISEASES | 2016-11-03 |
20160319003 | Anti-aP2 Antibodies and Antigen Binding Agents to Treat Metabolic Disorders | 2016-11-03 |
20160319004 | METHODS AND COMPOSITIONS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERS | 2016-11-03 |
20160319005 | METHODS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES USING CEREBLON AS A PREDICTOR | 2016-11-03 |
20160319006 | ANTIBODIES SPECIFIC FOR THE PROTOFIBRIL FORM OF BETA-AMYLOID PROTEIN | 2016-11-03 |
20160319007 | ADRENOMEDULLIN BINDER FOR USE IN THERAPY OF CANCER | 2016-11-03 |
20160319008 | METHOD OF TREATING WOUNDS | 2016-11-03 |
20160319009 | TREATMENT OF FIBRODYSPLASIA OSSIFICANS PROGRESSIVA | 2016-11-03 |
20160319010 | GLYCOENGINEERED BINDING PROTEIN COMPOSITIONS | 2016-11-03 |
20160319011 | SELF-BUFFERING PROTEIN FORMULATIONS | 2016-11-03 |
20160319012 | METHODS AND COMPOSITIONS COMPRISING PURIFIED RECOMBINANT POLYPEPTIDES | 2016-11-03 |
20160319013 | VACCINE TARGETING IL-17A | 2016-11-03 |
20160319014 | Anti-IL-12 Antibody Nucleic Acids and Methods | 2016-11-03 |
20160319015 | LEPTIN IN IMMUNE MODULATION | 2016-11-03 |